Hofseth BioCare raises NOK 200 million and intends to transfer to Oslo Børs
Hofseth BioCare ASA has recently announced the successful private placement of 24,691,358 shares at a price per share of NOK 8.10, corresponding to a total transaction size of NOK 200 million. In connection with the private placement, Hofseth BioCare has also announced that they wish to transfer their listing from Oslo Axess to Oslo Børs
Hofseth BioCare offers high-quality bio marine ingredients to human consumption. The company is founded on the core values of sustainability, traceability and optimal utilization of natural resources. Through innovative production technology Hofseth Biocare is able to preserve the quality of proteins, calicium and lipids from fresh salmon off-cuts. In this way Hofseth BioCare contributes to effective exploitation of marine resources.
The private placement was significantly oversubscribed.
CLP has advised Hofseth Biocare on the private placement and will advise on the transfer of listing.
CLP’s core team consists of Edvard Cock, Joakim Gjerde and Anja Fanebust.